Citius Pharmaceuticalsincis A Latestagebiopharmaceutical Company Based In Cranfordnjthecompany Focuses On Developing And Commercializing First In Class Critical Careproductstheir Innovativetreatments Span Several Therapeutic Areasincluding Anti Infectives In Oncologyadjunct Cancer Carestem Cell Therapyand Uniqueprescription Products Citius Pharmaceuticals Has A Diversepipelinefeaturing Several Key Productslymphira C Is An Fda Approved Targeted Immunetherapy For Adult Patients With Relapsed Or Refractory Cutaneous T Cell Lymphomamino Lok Is An Antibiotic Lock Solution Aimed At Treating Catheter Related Bloodstream Infectionsthecompany Is Also Advancing Citi 002Halo Lido A Topical Formulation For Hemorrhoid Reliefand Exploring Novecitemesenchymal Stem Cells For Acuterespiratory Conditionsparticularly Acuterespiratory Distress Syndromeards Citius Pharmaceuticals Is Committed To Improving Treatment Options For Patients And Caregivers Whilefocusing On Sustainablevaluefor Shareholders
